241
Participants
Start Date
March 21, 2011
Primary Completion Date
December 10, 2015
Study Completion Date
December 10, 2015
telbivudine
600 mg film-coated tablets taken as 600 mg once daily
tenofovir disoproxil fumarate
300 mg tablets taken as 300 mg once daily
Novartis Investigative Site, Vienna
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Varna
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Diyarbakır
Novartis Investigative Site, Majadahonda
Novartis Investigative Site, Hanover
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Izmir
Novartis Investigative Site, Tarragona
Novartis Investigative Site, Herne
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Trabzon
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Caserta
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Innsbruck
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Alexandroupoli
Novartis Investigative Site, Athens
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Athens
Novartis Investigative Site, Moscow
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY